연세대학교 · Medicine
Hyeon Chang Kim 교수의 연구실은 고혈압 및 만성질환 관리의 핵심 요소인 생체지표와 질병 예후 간의 연관성을 중심으로 연구를 진행하고 있습니다. 특히 간기능 지표인 아미노전이효소 농도가 정상 범위 내에서도 간질환 사망과의 관련성을 규명하며, 정상 범위 내에서도 조기 경고 지표로 활용할 수 있는 생체정보의 중요성을 제시하고 있습니다. 또한 한국의 고혈압 관리 현황을 분석하고, 연령, 성별, 공존질환을 고려한 맞춤형 예방 및 관리 전략 개발을 목표로 하며, 비전염성질환의 전반적 관리 체계 강화에 기여하고자 합니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
<h3>Abstract</h3> <b>Objective</b> To examine the relation between the normal range of serum aminotransferase concentration and mortality from liver disease. <b>Design</b> Prospective cohort study. <b>Setting</b> Korea Medical Insurance Corporation study with eight years9 follow up. <b>Participants</b> 94 533 men and 47 522 women aged 35-59 years. <b>Main outcome measure</b> Mortality from liver diseases according to death certificate. <b>Results</b> There was a positive association between the
In Korea, the level of hypertension management has considerably improved over the last 20 years. In order to achieve further improvement in hypertension management status, we need to find the vulnerable subgroups and develop subgroup-specific intervention strategies. It is also becoming more important to manage hypertensive patients at older age and those with concurrent chronic diseases.
A noncommunicable disease (NCD) is a medical condition or disease that is by definition non-infectious and non-transmissible among people. Currently, NCDs are the leading causes of death and disease burden worldwide. The four main types of NCDs, including cardiovascular disease, cancer, chronic lung disease, and diabetes, result in more than 30 million deaths annually. To reduce the burden of NCDs on global health, current public health actions stress the importance of preventing, detecting, and
To achieve further improvement in management of hypertension, we need to encourage awareness and treatment in young adults. It is required to develop tailored prevention and management strategies that are appropriate for and inclusive of various demographics.
Cardiovascular disease (CVD) is the leading cause of death and a major contributor to disability worldwide. Currently, Korea is among countries with the lowest CVD mortality rates, and the age-adjusted CVD mortality rate is still decreasing. However, depending on the CVD type, the mortality and incidence trends vary. Without age-standardization, cerebrovascular disease mortality peaked in 1994 (82.1 per 100K) and continued to decline until 2018 (44.7 per 100K), while heart disease mortality reco
The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been established. It is confirmed that higher blood pressure levels are associated with increased risk of cardiovascular disease and mortality also in the Korean population. About one third of Korean adults aged 30 years or older are estimated to have hypertension, and the prevalence of hypertension
